Immunogenicity and Safety of BNT162b2 in Juvenile Immune-Mediated Inflammatory Disease Patients
A new phase of COVID-19 vaccine evaluation is underway for a group often underrepresented in clinical trials: children and adolescents living with juvenile immune mediated...















